Mediastinal paragangliomas: Association with mutations in the succinate dehydrogenase genes and aggressive behavior

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Hans K. Ghayee - , University of Texas at Dallas (Autor:in)
  • Bas Havekes - , Eunice Kennedy Shriver National Institute of Child Health and Human Development, Leiden University (Autor:in)
  • Eleonora P.M. Corssmit - , Leiden University (Autor:in)
  • Graeme Eisenhofer - , Institut für Klinische Chemie und Laboratoriumsmedizin, Medizinische Klinik und Poliklinik III (Autor:in)
  • Stephen R. Hammes - , University of Texas at Dallas (Autor:in)
  • Zahid Ahmad - , University of Texas at Dallas (Autor:in)
  • Alexander Tessnow - , University of Texas at Dallas (Autor:in)
  • Ivica Lazúrová - , P. J. Safarik University (Autor:in)
  • Karen T. Adams - , Eunice Kennedy Shriver National Institute of Child Health and Human Development (Autor:in)
  • Antonio T. Fojo - , National Cancer Institute (NCI) (Autor:in)
  • Karel Pacak - , Eunice Kennedy Shriver National Institute of Child Health and Human Development (Autor:in)
  • Richard J. Auchus - , University of Texas at Dallas (Autor:in)

Abstract

Extra-adrenal pheochromocytomas, otherwise known as paragangliomas (PGLs), account for about 20% of catecholamine-producing tumors. Catecholamine excess and mutations in the genes encoding succinate dehydrogenase subunits (SDHx) are frequently found in patients with PGLs. Only 2% of PGLs are found in the mediastinum, and little is known about genetic alterations in patients with mediastinal PGLs, catecholamine production by these tumors, or their clinical behavior. We hypothesized that most mediastinal PGLs are associated with germ line SDHx mutations, norepinephrine and/or dopamine excess, and aggressive behavior. The objective of this study was to characterize genetic, biochemical, and clinical data in a series of ten patients with mediastinal PGLs. All ten primary mediastinal PGL patients had germ line SDHx mutations, six in SDHB, and four in SDHD genes. Chest or back pain were the most common presenting symptoms (five patients), and catecholamines and/or their metabolites were elevated in seven patients. Additional tumors included head and neck PGLs in four patients, pheochromocytoma in one patient, and bladder PGL in another. Metastatic disease was documented in six patients (60%), and a concurrent abdominal mass was found in one patient. We conclude that mediastinal PGLs are strongly associated with SDHB and SDHD gene mutations, noradrenergic phenotype, and aggressive behavior. The present data suggest that all patients with mediastinal PGLs should be screened for SDHx gene mutations, regardless of age.

Details

OriginalspracheEnglisch
Seiten (von - bis)291-299
Seitenumfang9
FachzeitschriftEndocrine-related cancer
Jahrgang16
Ausgabenummer1
PublikationsstatusVeröffentlicht - 2009
Peer-Review-StatusJa

Externe IDs

PubMed 19075037